Searchable abstracts of presentations at key conferences in endocrinology

ea0041d1.3 | The use of NSAIDs in endocrine cancers: the case of Celecoxib | ECE2016

The use of NSAIDs in endocrine cancers: the case of Celecoxib AGAINST

Sacchetti Andrea

The antitumor properties of non-steroidal anti-inflammatory drugs (NSAIDs), with respect to both cancer prevention and therapy, have raised considerable interest in the last two decades, leading to well consolidated evidences in gastrointestinal cancers, especially colorectal cancer. NSAID action has been proposed to occur through two independent modes: a COX-dependent one, mainly involving the inhibition of COX-2-mediated PGE2 production, and a COX-independent one, mainly inv...